Biotech
CAMBRIDGE, MASSACHUSETTS: VBI-1901 is a novel immunotherapy developed using VBI's eVLP technology On track to initiate a Phase I/2a clinical study in the second half of 2017 ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/15/17 -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV)(OTCQB: RVVTF), a company focused on the research, develop ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 08/14/17 -- (NASDAQ: CBLI) today reported financial results and development progress for the second quarter ended June 30, 2017.Cleveland BioLabs reported a net loss ...
TORONTO, ONTARIO: Clinical responses observed in Phase 1 trial of TTI-621; Scope of trial expanded, including dose-intensification strategy; $39 million capital raise; cash and marketable securities of $72.6 million at ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/10/17 -- Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF), announced today it has closed the non-brokered private placement the ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 08/09/17 -- Opthea Limited (ASX: OPT), a developer of novel biologic therapies for the treatment of eye diseases, announced today that the Company will presen ...
TORONTO, ONTARIO: $25 Million of Expected Sales, With Approximately $10 Million of New Business ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 08/02/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it has been notified by its partner, TaiMed Biologics, Inc. (TaiMed), that ...
MALVERN, PA: MALVERN, PA -- (Marketwired) -- 08/02/17 -- Realm Therapeutics (AIM: RLM)("Realm Therapeutics", "Realm" or the "Company")Realm Therapeutics plc (AIM: RLM), a clinical st ...
OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwired) -- 08/01/17 -- Mincom Capital Corporation ("Mincom" or the "Corporation") (TSX VENTURE: MOI) is pleased to provide the following update with resp ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/01/17 -- Bradmer Pharmaceuticals Inc. ("Bradmer" or the "Company") (NEX: BMR.H) today announced its second quarter 2017 financial results. ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/27/17 -- Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF) today provided an update on the progress of the good manufacturing pra ...
CAMBRIDGE, MASSACHUSETTS: Well tolerated at all doses with no safety signals 100% seroconversion at highest dose after two of the three planned vaccinations Dose-dependent antibody responses against CMV gB antigen Full data af ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 07/27/17 -- ANGLE PLC (AIM: AGL) (OTCQX: ANPCY)For Immediate ReleaseOTCQX: ANPCY("ANGLE" or "the Company")ANGLE plc (AIM: AGL OTCQX: ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 07/26/17 -- Radient Technologies Inc. (TSX VENTURE: RTI) (the "Company") announced today that it has released its financial results for the fiscal yea ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/24/17 -- Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF) announced today it has retained Mackie Research Capital Corporation (& ...
